TY  - RPRT
TI  - Real-world frontline treatments in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor exon 20 insertions and adjusted comparisons versus amivantamab plus chemotherapy from the PAPILLON study.
AU  - Christos Chouaid
AU  - Lise Bosquet
AU  - Craig Knott
AU  - Ziming Li
AU  - Marcy Schaeffer
AU  - Xiwu Lin
AU  - Claudio A Schioppa
AU  - Nolen Joy Perualila
AU  - Joris Diels
AU  - Eduardo Quintero Caparros
AU  - Francesca Galea
AU  - Annika Hultén
AU  - Alastair Greystoke
PY  - 2025
DO  - 10.1016/j.lungcan.2025.108548
UR  - https://pubmed.ncbi.nlm.nih.gov/40262227/
ID  - 40262227
ER  -